Category:Pharmaceuticals policy
Wikimedia Commons has media related to Pharmaceuticals policy.
Subcategories
This category has the following subcategory, out of 3 total.
(previous page) (next page)A
Pages in category "Pharmaceuticals policy"
The following 92 pages are in this category, out of 142 total. This list may not reflect recent changes.
(previous page) (next page)F
I
- Initiative for Medicines, Access, and Knowledge
- International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
- International Society for Pharmacoepidemiology
- International Society of Pharmacovigilance
- International Union of Basic and Clinical Pharmacology
- IPLEDGE program
- Irwin screen
M
- Pharmaceutical marketing
- Marketing authorisation
- Medical cannabis
- Medicare Part D
- Medicare Prescription Drug, Improvement, and Modernization Act
- Medication discontinuation
- List of medicine contamination incidents
- Medicines Act 1968
- Medicines reconciliation
- MIMS Ireland
- Multidrug-resistant tuberculosis
O
P
- 2012 Pakistan fake medicine crisis
- Patient group directions
- Pharmac
- Template:Pharmaceutical Affordability and Access
- Pharmaceutical Benefits Scheme
- Pharmaceutical distribution
- Pharmaceutical fraud
- Pharmaceutical industry in China
- Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme
- Pharmaceutical Press
- Pharmaceutical Price Regulation Scheme
- Pharmacovigilance
- Pharmacovigilance Programme of India
- Pledge to Africa Act
- Postmarketing surveillance
- Prescription drug
- Prescription Drug Marketing Act
- Prescription drug prices in the United States
- Prescription drug purchasing pool
- Prescription Drug User Fee Act
- Prescription monitoring program